Madrona Financial Services LLC Has $93,000 Holdings in Tilray Inc (NASDAQ:TLRY)

Madrona Financial Services LLC boosted its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 40.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,000 shares of the company’s stock after buying an additional 20,000 shares during the quarter. Madrona Financial Services LLC’s holdings in Tilray were worth $93,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in TLRY. BNP Paribas Financial Markets boosted its holdings in shares of Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after acquiring an additional 1,690,827 shares during the period. Point72 Asset Management L.P. bought a new stake in shares of Tilray during the third quarter worth approximately $1,348,000. Bank of Montreal Can boosted its holdings in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after acquiring an additional 355,778 shares during the period. XTX Topco Ltd boosted its stake in shares of Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock valued at $495,000 after buying an additional 257,641 shares during the period. Finally, Barclays PLC boosted its stake in shares of Tilray by 600.4% in the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock valued at $359,000 after buying an additional 174,997 shares during the period. Institutional investors own 9.35% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Roth Mkm cut their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th. Canaccord Genuity Group boosted their price target on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research note on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Tilray presently has an average rating of “Hold” and a consensus price target of $2.70.

Tilray Stock Up 0.4 %

Shares of TLRY opened at $1.14 on Thursday. Tilray Inc has a one year low of $1.12 and a one year high of $2.97. The company has a market cap of $1.06 billion, a P/E ratio of -3.82 and a beta of 2.08. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The firm has a 50 day simple moving average of $1.31 and a two-hundred day simple moving average of $1.59.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million for the quarter, compared to analyst estimates of $216.34 million. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. Research analysts forecast that Tilray Inc will post -0.2 EPS for the current fiscal year.

Insider Buying and Selling at Tilray

In related news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction dated Friday, November 15th. The stock was bought at an average cost of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the acquisition, the chief financial officer now owns 26,000 shares of the company’s stock, valued at approximately $35,360. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.87% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.